IMP: Report on Results of trading of shares by an internal shareholder

Report on Results of trading of shares by an internal shareholder of Imexpharm Corporation as follows:

1)     Name of individual: Mr. Nguyen Kiem Phuong

-  Current position (if available) in the organization listed/registered for trading, fund management company/public investment fund: Member of the Board of Directors

2)     Trading securities code: IMP

3)     Quantity and ratio of shares owned before conducting trading: 35,000 shares (0.12%)

4)     Quantity of shares/fund certificates registered for sale: 5,000 shares

5)     Quantity of shares already traded (sale): 5,000 shares

6)     Quantity and ratio of shares owned after conducting trading: 30,000 shares (0.10%)

7)     Purpose(s) of conducting trading: personal financial needs

8)     Method of trading: order matching

9)     Period for conducting trading: from January 22, 2015 to February 02, 2015

HOSE

>   KDC: Report on Results of trading of shares by an internal shareholder (04/02/2015)

>   TMS: Report on Results of trading of shares by an internal shareholder (04/02/2015)

>   E1VFVN30: NAV 2 Feb 2015 (04/02/2015)

>   FCN: Board resolution (04/02/2015)

>   ABT: Report on Outstanding Voting Shares (04/02/2015)

>   HDG: Notice of trading of shares by an internal shareholder (04/02/2015)

>   ABT: Notice of trading of shares by an internal shareholder (04/02/2015)

>   KDC: Notice of trading of shares by an internal shareholder (04/02/2015)

>   TTF: Resolution of Extraordinary General Meeting 2015 (04/02/2015)

>   SRF: Explanation for the parent company’s business performance in Q4.2014 (04/02/2015)